Biotherapeutics: recent developments using chemical and molecular biology
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
RSC Publishing
[2013]
|
| Schriftenreihe: | RSC drug discovery series
36 |
| Schlagworte: | |
| Beschreibung: | XIV, 316 Seiten Illustrationen, Diagramme |
| ISBN: | 9781849737159 1849737150 9781849736015 1849736014 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV043509931 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 160413s2013 a||| |||| 00||| eng d | ||
| 020 | |a 9781849737159 |9 978-1-84973-715-9 | ||
| 020 | |a 1849737150 |9 1-84973-715-0 | ||
| 020 | |a 9781849736015 |9 978-1-84973-601-5 | ||
| 020 | |a 1849736014 |9 1-84973-601-4 | ||
| 035 | |a (OCoLC)935164107 | ||
| 035 | |a (DE-599)BVBBV043509931 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 082 | 0 | |a 615.7 |2 23 | |
| 084 | |a VS 9400 |0 (DE-625)147728:253 |2 rvk | ||
| 245 | 1 | 0 | |a Biotherapeutics |b recent developments using chemical and molecular biology |c edited by Lyn H. Jones and Andrew J. McKnight |
| 264 | 1 | |a Cambridge |b RSC Publishing |c [2013] | |
| 264 | 4 | |c © 2013 | |
| 300 | |a XIV, 316 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a RSC drug discovery series |v 36 | |
| 505 | 8 | |a This book will illustrate the successful partnership of chemistry and biology to advance successful biotherapeutic modalities. Molecular design to create function is common to both chemical and molecular biology, and this text will highlight recent developments from these disciplines that have delivered drugs, clinical candidates or significantly advanced biotherapeutic approaches. Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding. Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book will provide essential reading for medicinal and pharmaceutical chemists working in both industry and academia | |
| 505 | 8 | |a Synthetic immunology -- Immunopharmacotherapy for nicotine addiction -- Carbohydrate vaccines -- Generation and maturation of therapeutic antibodies via in vitro somatic hypermutation -- Synthetic protein biologics -- Recent advances in antibody-drug conjugates -- MicroRNA biotherapeutics: key challenges from a drug development perspective -- Novel therapeutic agents from bacterial toxins -- Phage selection of mono- and bicyclic peptide ligands -- Chemical approaches for localization, characterization and mimicry of peptide epitopes -- Cystine-knot proteins | |
| 650 | 4 | |a Biopharmaceutics | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a Biological products / Therapeutic use |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Biological products |x Therapeutic use | |
| 700 | 1 | |a Jones, Lyn H. |4 edt | |
| 700 | 1 | |a McKnight, Andrew J. |4 edt | |
| 830 | 0 | |a RSC drug discovery series |v 36 |w (DE-604)BV036776227 |9 36 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028926149 | ||
Datensatz im Suchindex
| _version_ | 1804176150418685952 |
|---|---|
| any_adam_object | |
| author2 | Jones, Lyn H. McKnight, Andrew J. |
| author2_role | edt edt |
| author2_variant | l h j lh lhj a j m aj ajm |
| author_facet | Jones, Lyn H. McKnight, Andrew J. |
| building | Verbundindex |
| bvnumber | BV043509931 |
| classification_rvk | VS 9400 |
| contents | This book will illustrate the successful partnership of chemistry and biology to advance successful biotherapeutic modalities. Molecular design to create function is common to both chemical and molecular biology, and this text will highlight recent developments from these disciplines that have delivered drugs, clinical candidates or significantly advanced biotherapeutic approaches. Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding. Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book will provide essential reading for medicinal and pharmaceutical chemists working in both industry and academia Synthetic immunology -- Immunopharmacotherapy for nicotine addiction -- Carbohydrate vaccines -- Generation and maturation of therapeutic antibodies via in vitro somatic hypermutation -- Synthetic protein biologics -- Recent advances in antibody-drug conjugates -- MicroRNA biotherapeutics: key challenges from a drug development perspective -- Novel therapeutic agents from bacterial toxins -- Phage selection of mono- and bicyclic peptide ligands -- Chemical approaches for localization, characterization and mimicry of peptide epitopes -- Cystine-knot proteins |
| ctrlnum | (OCoLC)935164107 (DE-599)BVBBV043509931 |
| dewey-full | 615.7 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.7 |
| dewey-search | 615.7 |
| dewey-sort | 3615.7 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03006nam a2200445zcb4500</leader><controlfield tag="001">BV043509931</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">160413s2013 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781849737159</subfield><subfield code="9">978-1-84973-715-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1849737150</subfield><subfield code="9">1-84973-715-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781849736015</subfield><subfield code="9">978-1-84973-601-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1849736014</subfield><subfield code="9">1-84973-601-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)935164107</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043509931</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9400</subfield><subfield code="0">(DE-625)147728:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biotherapeutics</subfield><subfield code="b">recent developments using chemical and molecular biology</subfield><subfield code="c">edited by Lyn H. Jones and Andrew J. McKnight</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">RSC Publishing</subfield><subfield code="c">[2013]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 316 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">RSC drug discovery series</subfield><subfield code="v">36</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">This book will illustrate the successful partnership of chemistry and biology to advance successful biotherapeutic modalities. Molecular design to create function is common to both chemical and molecular biology, and this text will highlight recent developments from these disciplines that have delivered drugs, clinical candidates or significantly advanced biotherapeutic approaches. Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding. Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book will provide essential reading for medicinal and pharmaceutical chemists working in both industry and academia</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Synthetic immunology -- Immunopharmacotherapy for nicotine addiction -- Carbohydrate vaccines -- Generation and maturation of therapeutic antibodies via in vitro somatic hypermutation -- Synthetic protein biologics -- Recent advances in antibody-drug conjugates -- MicroRNA biotherapeutics: key challenges from a drug development perspective -- Novel therapeutic agents from bacterial toxins -- Phage selection of mono- and bicyclic peptide ligands -- Chemical approaches for localization, characterization and mimicry of peptide epitopes -- Cystine-knot proteins</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biopharmaceutics</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biological products / Therapeutic use</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological products</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jones, Lyn H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McKnight, Andrew J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">RSC drug discovery series</subfield><subfield code="v">36</subfield><subfield code="w">(DE-604)BV036776227</subfield><subfield code="9">36</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028926149</subfield></datafield></record></collection> |
| id | DE-604.BV043509931 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:27:36Z |
| institution | BVB |
| isbn | 9781849737159 1849737150 9781849736015 1849736014 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028926149 |
| oclc_num | 935164107 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | XIV, 316 Seiten Illustrationen, Diagramme |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | RSC Publishing |
| record_format | marc |
| series | RSC drug discovery series |
| series2 | RSC drug discovery series |
| spelling | Biotherapeutics recent developments using chemical and molecular biology edited by Lyn H. Jones and Andrew J. McKnight Cambridge RSC Publishing [2013] © 2013 XIV, 316 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier RSC drug discovery series 36 This book will illustrate the successful partnership of chemistry and biology to advance successful biotherapeutic modalities. Molecular design to create function is common to both chemical and molecular biology, and this text will highlight recent developments from these disciplines that have delivered drugs, clinical candidates or significantly advanced biotherapeutic approaches. Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding. Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book will provide essential reading for medicinal and pharmaceutical chemists working in both industry and academia Synthetic immunology -- Immunopharmacotherapy for nicotine addiction -- Carbohydrate vaccines -- Generation and maturation of therapeutic antibodies via in vitro somatic hypermutation -- Synthetic protein biologics -- Recent advances in antibody-drug conjugates -- MicroRNA biotherapeutics: key challenges from a drug development perspective -- Novel therapeutic agents from bacterial toxins -- Phage selection of mono- and bicyclic peptide ligands -- Chemical approaches for localization, characterization and mimicry of peptide epitopes -- Cystine-knot proteins Biopharmaceutics MEDICAL / Pharmacology bisacsh Biological products / Therapeutic use fast Medizin Biological products Therapeutic use Jones, Lyn H. edt McKnight, Andrew J. edt RSC drug discovery series 36 (DE-604)BV036776227 36 |
| spellingShingle | Biotherapeutics recent developments using chemical and molecular biology RSC drug discovery series This book will illustrate the successful partnership of chemistry and biology to advance successful biotherapeutic modalities. Molecular design to create function is common to both chemical and molecular biology, and this text will highlight recent developments from these disciplines that have delivered drugs, clinical candidates or significantly advanced biotherapeutic approaches. Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding. Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book will provide essential reading for medicinal and pharmaceutical chemists working in both industry and academia Synthetic immunology -- Immunopharmacotherapy for nicotine addiction -- Carbohydrate vaccines -- Generation and maturation of therapeutic antibodies via in vitro somatic hypermutation -- Synthetic protein biologics -- Recent advances in antibody-drug conjugates -- MicroRNA biotherapeutics: key challenges from a drug development perspective -- Novel therapeutic agents from bacterial toxins -- Phage selection of mono- and bicyclic peptide ligands -- Chemical approaches for localization, characterization and mimicry of peptide epitopes -- Cystine-knot proteins Biopharmaceutics MEDICAL / Pharmacology bisacsh Biological products / Therapeutic use fast Medizin Biological products Therapeutic use |
| title | Biotherapeutics recent developments using chemical and molecular biology |
| title_auth | Biotherapeutics recent developments using chemical and molecular biology |
| title_exact_search | Biotherapeutics recent developments using chemical and molecular biology |
| title_full | Biotherapeutics recent developments using chemical and molecular biology edited by Lyn H. Jones and Andrew J. McKnight |
| title_fullStr | Biotherapeutics recent developments using chemical and molecular biology edited by Lyn H. Jones and Andrew J. McKnight |
| title_full_unstemmed | Biotherapeutics recent developments using chemical and molecular biology edited by Lyn H. Jones and Andrew J. McKnight |
| title_short | Biotherapeutics |
| title_sort | biotherapeutics recent developments using chemical and molecular biology |
| title_sub | recent developments using chemical and molecular biology |
| topic | Biopharmaceutics MEDICAL / Pharmacology bisacsh Biological products / Therapeutic use fast Medizin Biological products Therapeutic use |
| topic_facet | Biopharmaceutics MEDICAL / Pharmacology Biological products / Therapeutic use Medizin Biological products Therapeutic use |
| volume_link | (DE-604)BV036776227 |
| work_keys_str_mv | AT joneslynh biotherapeuticsrecentdevelopmentsusingchemicalandmolecularbiology AT mcknightandrewj biotherapeuticsrecentdevelopmentsusingchemicalandmolecularbiology |